1. Introduction
Wnt glycolipoproteins are extracellular ligands that can be found in many species, ranging from the sea anemone to human [1]. Wnts are signaling factors regulating several key developmental processes, such as proliferation, differentiation, asymmetric division, patterning and cell fate determination [2,3]. The Wnt family consists of 19 lipid modified secreted glycoproteins that are primarily divided into two main categories based on their role in cytosolic β-catenin stabilization: canonic and non canonic [4,5,6]. During canonical Wnt signaling, binding of Wnt ligands to Frizzled/low-density lipoprotein-related protein (LRP) receptor complexes causes a stabilization of β-catenin, which is normally degraded by axin/glycogen synthase kinase-3 (GSK-3)/adenomatous polyposis coli (APC) complexes. Stabilized β-catenin is then able to translocate to the nucleus and through interactions with the T-cell factor (Tcf)/ lymphoid enhancer factor 1 (LEF-1), modulates the expression of specific genes [7]. These genes, by regulating cell proliferation, differentiation, adhesion, morphogenesis are involved in various essential physiological and physiopathological processes as embryonic and adult development, cellular and tissular homeostasis, and diseases [8,9,10,11,12]. In contrast, the less-characterized non-canonical Wnt pathways are independent of β-catenin and transduce Wnt signals through numerous signaling, including either c-Jun NH2-terminal kinases (JNK)/planar cell polarity or Wnt/calcium pathways [13,14,15,16,17].
During development, Wnts act as morphogens and control the patterning of the embryo by triggering concentration-dependent autocrine and paracrine responses [18,19,20]. Globally, Wnts are involved in the embryonic myogenesis by regulating the activity of myogenic regulatory factors (MRF).
Whereas data are well established concerning the functions of Wnt proteins during embryonic muscle development, the knowledge of the implications of Wnt signaling in adult muscle regeneration and homeostasis is much less advanced. The ability of skeletal muscle to grow, maintain, and regenerate itself is dependent on a population of satellite cells, a specialized pool of adult myogenic stem cells, that reside in between the muscle basal lamina and the cell membrane of myofibers. Satellite cells generate muscle precursor cells that then proliferate before they either fuse into an existing myofiber to become post-mitotic nuclei or fuse together to form myotubes [21,22,23]. Accumulating data show that among the signaling proteins, members of the Wnt family are strongly implicated in the adult skeletal muscle development, growth and regeneration [24,25,26,27].
The role of Wnt signaling in myoblast differentiation is supported by the fact that myostatin (Mstn), a member of the transforming growth factor-β (TGF-β) superfamily, negatively regulates muscle mass via non-canonical Wnt signaling pathways [28]. Mstn is an important regulator of skeletal muscle development and adult homeostasis. Naturally occurring mutations, as well as experimental knockout of the
In this review, we will detail Wnt signaling pathways, their implications during embryonic and adult skeletal myogenesis. A particular attention will be paid to the relation between Wnt factors, particularly Wnt4 and myostatin.
2. Wnt signaling
2.1. Components of the Wnt signaling pathway
2.1.1. Wnts, the ligands
Wnt proteins constitute a large family of cystein-rich secreted glycolipoproteins that control development in organisms ranging from nematode worms to mammals [38]. To date, at least 19 Wnt genes have been identified in mammals; they are similar in size, ranging from 39 kDa to 46 kDa [39,40,41]. All Wnts have a signal sequence followed by a highly conserved distribution of cysteine residues, the spacing of which is highly conserved, suggesting that Wnt protein folding may depend on the formation of multiple intra-molecular disulfide bonds [42,43]. Once secreted, Wnt ligands remain tightly associated with the extracellular matrix, with a strong affinity for heparin sulfate proteoglycans [44,45]. In addition, Wnt ligands are carried on lipoprotein particles to facilitate signaling activities in the intercellular space [46,47,48]. Although Wnts are secreted proteins, they are highly insoluble and have therefore been difficult to be purified [39,49]. As a consequence, very little is known about the structure and biochemical properties of Wnt proteins. They mediate their signaling activity through the interaction with the seven transmembrane Frizzled (Fzd) receptor and the co-receptor LDL-receptor related protein (LRP) [50,51,52]. The Wnt family members can be divided in two distinct classes depending on their ability to induce transformation of the mouse mammary epithelial cell line C57MG [53]. The highly transforming members include Wnt1, Wnt3, Wnt3a, and Wnt7a. The intermediately transforming or non-transforming members include Wnt2, Wnt4, Wnt5a, Wnt5b, Wnt6, Wnt7b, and Wnt11 [54]. These two groups of Wnts signal via intracellular pathways that trigger different developmental outcomes [53]. In mammals, highly transforming Wnts have been associated to the canonical Wnt/β-catenin pathway, whereas non-transforming Wnts have been associated activate to the non-canonical pathway [4,6]. It is noteworthy that this binary classification is becoming obsolete, thus although Wnt4 was originally described as a non-canonical Wnt (non-transforming Wnt), it has also been implicated in the activation or inhibition of the canonical Wnt pathway [55,56,57,58,59,60,61]. Wnt7a has also been implicated in both canonical and non-canonical Wnt signaling depending on the cell and tissue context [62,63]. Non-canonical Wnt signaling pathways are less well defined, but appear to function in a β-catenin independent manner to regulate processes such as convergent extension during vertebrate gastrulation, and planar polarity [64,65,66,67,68].
2.1.2. Frizzled, the receptors
Frizzled genes encode membrane proteins that mediate multiple signal transduction pathways. They have been identified in diverse animals, from sponges to humans. These proteins belong to the family of G protein-coupled receptor proteins which act as receptors for secreted Wnts [51,69,70]. Ten frizzled proteins have been identified in mouse and humans, and all share the following structural similarities: a signal peptide sequence at the amino terminus, a conserved region of 120 amino acids in the extracellular domain containing 10 invariantly spaced cysteines (called the cysteine rich domain CRD), a seven-pass transmembrane region, in which the transmembrane segments are well conserved, and a cytoplasmic domain with little homology among members of the family [71,72,73,74]. The structure of CRD domain has been solved and it appears to be necessary and sufficient for binding to Wnt [74,75]. Fzds are coupled with trimeric G proteins, and the Wnt stimulated pathway is sensitive to inactivation by pertussis toxin. Specificity of the Wnt-Fzd interaction remains largely unknown, particularly in vertebrates, because of the large numbers of Wnts and Fzds [76,77,78].
2.1.3. LRPs, the co-receptors
Low-density receptor-related protein 5 and 6 (LRP-5 and LRP-6), which are highly homologous, are members of the low-density-lipoprotein (LDL) family of receptors [79,80]. LRP functions as a co-receptor for Wnt signaling leading to the activation of the Wnt/β-catenin pathway. LRP-5 and LRP-6 are type I single-span transmembrane proteins [81,82,83]. LRP-5 and -6, which bind to Axin through their intracellular domain, are key signaling receptors for the β-catenin pathway [84,85]. The binding between LRP5 and LRP6 is directly associated to the stabilization of β-catenin [79].
2.1.4. Secreted modulators of the Wnt pathway
The extracellular antagonists of the Wnt signaling pathway can be divided into two broad classes. The first class, which includes the secreted Frizzled receptor (sFRP), primarily binds to Wnt proteins; the second class comprises the Dickkopf (Dkk) family, which binds to the LRP subunit of the Wnt receptor complex [86,87,88]. Both classes of molecules prevent ligand-receptor interactions by different mechanisms [89]. sFRPs share homology in the N-terminal region with the cysteine-rich domain of Frizzled proteins, but lack the transmembrane domain [90,91]. sFRPs inhibit Wnt signaling by competing with Fzd for Wnt ligands or in a dominant negative fashion by forming a non-signaling complex with Wnt [92]. There are presently five known members of the family in mouse, sFRP1 to sFRP5. sFRPs are composed of a cysteine rich domain (CRD) and a domain that shares weak sequence similarity with the axon guidance protein netrin (NTR) in the C-terminus [93,94]. The CRD shares 30-50% sequence similarity with those of Fzd proteins and includes 10 conserved cysteine residues.
The four members of the Dickkopf (Dkk) family (Dkk-1 to Dkk-4), inhibit Wnt signaling by binding to the LRP-5 and LRP-6 components of the receptor complex [87,95]. Dkks contain two characteristic cysteine-rich domains (Cys-1 and Cys-2) separated by a linker region of variable length. Cys-2, in particular, is highly conserved among all 69 members of the family and contains 10 conserved cysteine residues [88,89].
2.1.5. Dishevelled
Dishevelled (
The Planar cell polarity pathway makes use of
2.2. The canonical or Wnt/β-catenin pathway
Wnt family glycoproteins are primarily divided into two main categories based on their role in cytosolic β-catenin stabilization: canonic and non-canonical [4,5,6,100] (Figure 1). Signaling through the Wnt/β-catenin pathway also called canonical pathway, modify the stabilization of β-catenin. In the absence of Wnt binding to Frizzled receptors, β-catenin is targeted for degradation by a multi-protein destruction complex composed of the tumor suppressor protein APC (
2.3. Non-canonical signaling pathways
In contrast, non-canonical Wnts transduce their signal independently of β-catenin. The non-canonical Wnt signaling pathway has been found to be associated with gastrulation movements, heart induction, dorsoventral patterning, tissue separation and neuronal migration [6]. Unlike the canonical Wnt signaling pathway, the non-canonical Wnt signaling pathway is quite diverse. Thus, it has been reported that non-canonical Wnts can activate calcium flux, G proteins, Rho GTPases, or c-Jun N-terminal kinase (JNK) [6,66,82].
The response to a given stimulus depends not only on which Wnt is present, but also on which cognate receptor is expressed on the cell [118], It is likely that one Wnt protein can signal more than one type of response in a cell if multiple types of receptors are present [58]. Adding still more layers of complexity, cofactors, secreted antagonists and co-receptors of Wnt signalling are likely to affect both canonical and non-canonical actions [89,119].
2.3.1. Calcium pathway
Activation of this signaling pathway involves Wnt binding to a Frizzled receptor, subsequent release of intracellular calcium associated with the activation of various enzymes such as Ca2+/calmodulin-dependent (CamKII) protein kinase and Protein Kinase C (PKC) [6,120,121,122] (Figure 1). Here, frizzled receptors act through G-protein and activate phospholipase C (PLC) and phosphodiesterase (PDE), which lead to increased concentrations of free intracellular calcium and to decreased cyclic guanosine monophosphate (cGMP) [121,123,124]. Elevated free intracellular calcium can activate the phosphatases calcineurin, leading to dephosphorylation and activation of the transcription factor NFAT [14].
2.3.2. Planar cell polarity pathway
The planar cell polarity (PCP) pathway regulates the orientation and migration of polarized cells during development and defects underlie severe abnormalities [66,67,125]. Although, the regulation of this pathway appears to be incredibly complex, in vertebrates, it signals mainly through the JNK pathway. Upon binding of Wnt to its receptor Frizzled, there is activation of Disheveled, JNK and Rho family GTPases, which direct asymmetric cytoskeletal organization and coordinated polarization of cells within the plane of epithelial sheets [68,126,127] (Figure 1).
3. Implication of Wnt signaling in skeletal myogenesis
3.1. Embryonic skeletal myogenesis
Like any process of tissue development, skeletal muscle development is under the control of two regulation pathways: an intrinsic pathway implicating transcription factors (Pax3, Pax7, Myf5, MyoD1, Mrf4, Myogenin, Six proteins, SRF….) and an extrinsic pathway implicating external factors as Wnt, sFRP, Myostatin, Sonic Hedgehog (
3.1.1. Intrinsic pathway
Muscles of the trunk and limbs of vertebrate embryos are derived from somites. These segmental masses correspond to a series of transient repeated epithelial structures that derive from the paraxial mesoderm and lie on either side of the neural tube [128]. Somites eventually differentiate into five major cell types: cartilage, bone, and tendons of the trunk, skeletal muscles of the body and the dermis of the back [128,129,130,131]. This process is regulated by sonic hedgehog (
3.1.2. Extrinsic pathway
Numerous environmental paracrine factors are associated to the regulation of skeletal myogenesis, thus, for example, Notch signaling plays a role in cell fate determination in the lateral dermomyotome [147], in the amplification of Pax3+/Pax7+ progenitors cells and in the myoblastic proliferation [148].
Overall, Wnt protein family has been determined along with
In response to
In a remarkable study realized from chicken cultures of presomitic mesoderm cells, A.E Munsterber et al. have shown that Wnts could mimic the inducer effect of the dorsal neural tube and that
In mouse, similar experiments indicated that the expression of Myf5 is induced by a signal emanating from neural tube and that the expression of MyoD is depending of a signal coming from surface ectoderm [156]. Wnt7a secreted by the surface ectoderm and Wnt1/Wnt3a secreted by dorsal neural tube regulate MyoD and Myf5 expression, respectively whereas Wnt4 and Wnt5a regulate both MyoD and Myf5 expression [132]. Furthermore, it has been shown that Wnt1, Wnt3a and Wnt4 are expressed in the dorsal half of the neural tube when epaxial myogenesis is initiated [153]. Regulation of hypaxial muscle specification is less understood but Tajbakhsh et al, 1998 have shown that Wnt7a and to a lesser extent Wnt4 and Wnt5a can activate myogenesis in mouse paraxial mesoderm explants [132]. Conversely, sFRPs, inhibitor of Wnt signaling, markedly reduce myogenesis by antagonizing Wnts [157,158].
Use of somites from transgenic mice expressing lacZ reporter gene under the control of Myf5 epaxial promoter in presence of a constitutive form of β-catenin or in presence of the neural tube lead to a strong activation of the reporter, indicating that the Wnts secreted by the neural tube act mainly through canonical pathway [159]. In the surface ectoderm, signaling pathway initiated by Wnt7a differs from that by Wnt1. Wnt7a binds to Frz7 and signals through Protein kinase C, a β-catenin independent pathway [122,149]. Recently, the Wnt PCP pathway has been implicated in regulating the orientation of myocyte growth in the developing myotome [160]. As reported during osteogenic differentiation or during recruitment, maintenance, and differentiation of human bone marrow mesenchymal stem cells a cross-talk between canonical and non-canonical Wnt signaling exists and may lead to functional antagonism [161,162].
In chick embryos, Nohno's group analyzed the myogenic effects of Wnt4 overexpression in the limb bud in order to evaluate the significance of this factor in skeletal muscle formation during embryogenesis. They found that Wnt4 treatment induced an increase in the muscle mass, particularly in fast-type muscle size. Furthermore, ectopic Wnt4 induces muscle satellite markers Pax7 and MyoD expression [60].
As extrinsic factors, myostatin (Mstn), a member of the TGF-β superfamily, has been proposed as a regulator of embryonic myogenesis [30,32,34,163,164,165,166]. Myostatin, also called GDF8 (growth differentiation factor 8), is a secreted growth factor that belongs to the transforming growth factor-β (TGF-β) superfamily of growth and differentiation factors [30]. In mice, myostatin is predominantly expressed in skeletal muscle tissues from the period of embryogenesis to adulthood suggesting a role for this factor in the control of muscle development and function [30,166]. The role of myostatin in muscle comes from the phenotype of myostatin-deficient animals. Myostatin was first found to regulate muscle mass in mice from which the gene encoding myostatin has been knocked-out. The resulting “mighty mice” displayed muscle overgrowth due to both hyperplasia (increased number of muscle fibers) and hypertrophy (increased size of individual muscle fibers). These effects on muscle mass are persistent throughout the life of the animals. The phenotype of these mice suggested that myostatin functions as a negative regulator of muscle growth. Interestingly, the function of myostatin appears to have been conserved across diverse species. Natural mutations in the myostatin gene have been identified in double-muscled animals such as the Belgian blue cattle [29,167,168]. The recent identification of a hypermuscular child with a loss-of-function mutation in the myostatin gene suggests that the function of myostatin is similarly conserved in humans [169]. In support of this, myostatin sequence has been highly conserved through evolution, among species ranging from zebrafish to humans [30]. At early embryonic stages, myostatin expression is restricted to the myotome compartment of the developing somites, and myostatin has been proposed to play an essential role in skeletal muscle growth and development [30,165].
It is of note that many others autocrine or paracrine factors, such as Notch, Tgf-β1, Bmp, Noggin, mi-RNA…, play a subtle but crucial role in orchestrating the regulation of embryonic myogenesis [170,171,172,173,174,175,176]. Undoubtedly, the complete decoding of this intricate network will take several years to be complete.
3.2. Postnatal myogenesis
3.2.1. Satellite cells
The main role of satellite cells during the early postnatal period is to provide myonuclei for skeletal muscle growth. They contribute to the postnatal growth of syncital muscle cells, which in adults contain approximately 6–8 times more nuclei than in neonates [177]. In adult muscle, satellite cells are mitotically quiescent and do not express myogenic regulatory factors (MRFs) [178,179]. Their role changes to one of providing myonuclei for homeostasis and hypertrophy or in response to the more sporadic demands for myofiber repair and regeneration [180]. In the latter context, satellite cell activation is dramatically enhanced; they reenter the cell cycle and proliferate [181,182], at this stage they are often referred to as either myogenic precursor cells or myoblasts [182,183]. Some resulting myoblasts differentiate and fuse to form replacement myofibers, whereas some remain as continual dividing cells to replenish the pool of satellite cells in anticipation of future rounds of regeneration [182,184].
Pax7 is expressed in quiescent as well as activated satellite cells, and it is down regulated when satellite cells commit to muscle differentiation [177,185,186]. Compared to embryonic satellite cells, quiescent adult satellite cells do not require Pax7 for self-renewal and regeneration [187]. The progression of activated satellite cells toward myogenic differentiation is mainly controlled by Myf5 and MyoD [188] and is followed by fusion into regenerating fibers. Satellite cells undergo different fates, giving rise to a few Pax7+MyoD– cells, which return to quiescence (satellite stem cell population), and many Pax7+MyoD+ cells, which differentiate [189]. These asymmetric divisions are mainly regulated by Notch signaling [190,191,192]. In addition, satellite stem cells which represent approximately 10% of Pax7+ mouse satellite can undergo planar symmetric cell divisions to drive expansion of their population [190]. By a subtractive hybridization approach, Legrand et al. found that Wnt7a is expressed during muscle regeneration and acts through Fzd7 receptor to induce symmetric satellite stem cell expansion and thus enhance muscle regeneration. Wnt7a signaling though Frz7 receptor requires association with Vangl2, a membrane protein involved in the regulation of PCP suggesting that Wnt7a utilizes this non-canonical pathway to control the orientation of satellite cell division [62]. They suggest that Wnt7a regulates the homeostatic maintenance of the satellite stem cell pool by modulating the increase in satellite stem cell expansion during regenerative myogenesis and that basal levels of PCP signaling are insufficient to maintain the satellite cell pool at normal levels [62].
Aging is accompanied by a decline in muscle mass and strength, a phenomenon referred as to sarcopenia [193]. It is clear that fitness is greater at any age in individuals who exercise regularly versus those who do not and that sarcopenia is reduced in physically active elderly people. A decline in the number of satellite cells, their proliferative capacities, or both, may contribute to sarcopenia. One of the mechanisms responsible for the reduced regenerative potential of old muscle seems to be the decline in Notch signaling [194]. Aging of skeletal muscle is characterized by an increase in fibrous connective tissue and adipose tissue and by an impairment of muscle regenerative potential [195,196]. This decrease of aged-muscle regeneration can be enhanced by direct activation of the Notch pathway [194] or by exposure to a youthful systemic environment [197]. Very interestingly, these age-related effects are associated with increased canonical Wnt signaling in the satellite cell population, possibly resulting from increased amounts of Wnt or Wnt-like molecules in the serum of aged animals [24]. This generalized role of Wnt signaling in promoting an aging phenotype is consistent with the findings of Liu et al. [198].
3.2.2. Non satellite cells
Interestingly, a variety of non-satellite cell, located outside the basal lamina can also participate in skeletal muscle regeneration in the adult. These include pericytes, endothelial cells, mesoangioblasts [177,199,200,201,202], and interstitial cells (PICs) [203], as well as other cell types that are not fully characterized [26,204,205]. Polesskaya et al. found that a side population of cells harboring surface markers CD45 and Sca1 (CD45+:Sca1+) isolated from regenerating muscle readily underwent myogenic differentiation
3.2.3. Wnt-related regulation of myoblast proliferation and differentiation
In addition to the crucial role of Wnt proteins in satellite cells fate and maintenance, they play an essential role in the control of proliferation and differentiation in various cellular types.
In order to better characterize the role of Wnt proteins in the control of muscle cell differentiation, Bernardi et al. established Wnt expression pattern on C2C12 myoblasts and satellite cells [37]. They found that, among the 19 existing Wnts, only the expression of Wnt4 was strongly activated from the early steps of differentiation. Interestingly, by modulating Wnt4 expression level with overexpression or silencing approaches, they reported a strong differentiation promoting activity of this factor (Figure 3). The relative increase in myotube size being comparable 48, 72, and 96 h after switching to differentiation medium indicates that Wnt4 signaling controls myotube size at the early steps of differentiation during myotube formation. The lack of Wnt4-mediated hypertrophic effect observed when cells were transfected the day of differentiation or later indicates that this factor has to be expressed during the proliferative stage to be effective.
Fusion consists of two distinct phases: myoblast/myoblast fusion to form nascent myotubes and subsequent myoblast/myotubes fusion, resulting in a rapid accretion of size. The efficiency of the first phase can be evaluated by measuring the fusion index, which represents the proportion of the total cell population that has fused. After being switched to differentiation medium, Wnt4 overexpression in C2C12 and satellite cells gave a 62% and a 67% fusion index increase, respectively, suggesting that Wnt4 signaling control nascent myotube formation. Recently, Tanaka et al. confirms that Wnt4 overexpression increased troponin-T positive cells in proliferation medium and enhanced myotube formation of differentiated C2C12 cells [206].
Takata et al. reported that Wnt4 exhibited a low but significant myogenic activity with an increase of proliferation rate in myoblast cells [60]. Conversely, Otto and co-workers found, using co-culture of Wnt4-producing NIH-3T3 cell line on single muscle fiber culture, a 24% reduction of satellite-cell proliferation [207]. These conflicting results could be attributed either to the different specificities of the cellular models used or to the fact that effective concentration and physiological activity of ectopicWnt4 can be eminently variable, depending on the nature and activity of produced Wnt4. Taken together, these data are in agreement with a modest effect of Wnt4 on proliferation, suggesting a role of this factor in enhancing cell fusion rather than controlling the number of nuclei available for fusion.
Knockdown of Wnt4 expression in C2C12 and satellite cells inhibits their differentiation and further confirms that Wnt4 acts as an effector of myogenesis (Figure 3). However, addition of siWnt4 after switching to differentiation medium or 24 h before did not decrease significantly the differentiation rate. This confirms that Wnt4 acts as a positive regulator of myogenic differentiation only if it is expressed in the proliferative phase.
Myoblastic differentiation involves two major steps, their reversible withdrawal from cell cycle and the subsequent expression and activation of myogenic factors. Myf5 and MyoD are expressed in early myogenesis. As cells progress toward a differentiated phenotype, myogenin and MRF4 are induced and cooperatively establish the irreversible commitment to terminal differentiation. Myf5 is a factor reported to be high in the Go phase, where cells were arrested to differentiate [208]. Borello et al. have previously showed a direct regulation of Myf5 expression by canonical Wnt signaling during somitogenesis [2]. Bernardi et al. found that the expression of Myf5 was activated by Wnt4 overexpression and strongly inhibited by Wnt4 silencing during C2C12 myoblast and satellite cells differentiation, suggesting that myogenic activity of Wnt4 is related to an increase of Myf5 expression.
These authors by measuring Tcf/LEF gene canonical reporter activity and axin2 expression (a protein induced by canonical Wnt pathway), in the presence or absence of canonical Wnt pathway stimulators (LiCl or BIO), reported canonical Wnt pathway activation by Wnt4. Although this factor was originally described as a non-canonical Wnt, it has also been implicated in the activation or inhibition of the canonical Wnt pathway [55,56,57,58,59,60,61]. Numerous reports showed that Wnt-related myogenic activity is mediated mainly through a stimulation of canonical signaling. Thus, Takata et al. found that myogenic activity of Wnt4 is linked to an increase of β-catenin signaling [60]. Likewise, Armstrong et al. have reported that the expression of β-catenin is necessary for physiological growth of skeletal muscle and that Wnt signaling pathway induces β-catenin activation of growth-control genes during overload induced skeletal muscle hypertrophy [209,210]. By using C2C12 and satellite cells, Han et al. reported recently that activation of canonical pathway by R-spondin2, promote myogenic differentiation and hypertrophic myofiber formation [211]. When LiCl was added to the culture medium, the area of myotubes and index fusion were increased in both C2C12 and satellite cells, reaching values similar to those observed after Wnt4-induced hypertrophy [37]. On the other hand, the fact that LiCl exerts a higher Tcf/LEF activation than Wnt4 treatment, whereas the extent of differentiation is the same suggests that this process is dependent on other signaling pathways. In this respect, work of Otto et al. (61) on isolated muscle fibers showed that Wnt4 inhibited satellite cell proliferation but that canonical Wnts such as Wnt1, Wnt3a, and Wnt5a induced a greater degree of proliferation than control cells, confirming the implication of other pathways in Wnt4 signaling [207]. The stronger activity in terms of Tcf/LEF activation of LiCl compared with Wnt4 (+100% on C2C12 myoblasts, +250% on satellite cells) treatments could explain the discrepancy between proliferative activities of Wnt4 and LiCl. Indeed, as described above, Wnt4 shows a weak effect on mitogenicity, whereas 10 mM LiCl has a strong anti-proliferative activity (-15% on satellite cells, -48% on satellite cells), suggesting that low levels of Tcf/LEF activation regulate myogenic differentiation, whereas higher levels regulate preferentially the proliferation. A study reported by Anakwe et al. is also in agreement with a relation between the level of Tcf/LEF activity and the type of cellular response elicited [209]. They reported an increase in the number of terminally differentiated cells in Wnt4 transfected myogenic cells, whereas the overexpression of canonical Wnt3a decreases the number of terminally differentiated myogenic cells. Making more complex the Wnt4-related signaling in muscle, Tanaka et al. showed very recently that Wnt4 promotes myogenesis and suppresses canonical Wnt signaling, culture conditions and C2C12 myoblasts characteristics may be at the origin of this discrepancy and suggest that data emanating from established cell lines should be considered with care [206]. Moreover, the analysis of cellular response during myoblast differentiation can be made more complex by the implication of other signaling pathways like the non-canonical Wnt/calcium signaling.
Recently, an elegant work from Rudnicki's group showed that Wnt signaling is also implicated in the control of muscular hypertrophy [27]. Skeletal muscle mass depends upon a dynamic balance between anabolic and catabolic processes. Muscle hypertrophy is characterized by an increase of the diameter of muscle fibers and increased protein synthesis, mainly by activation of the IGF1/Akt/mTORC1 pathway. They observed that Wnt7a binding to Fzd7 receptor directly activates the Akt/mTOR growth pathway, thereby inducing myofiber hypertrophy. Besides, they found that anabolic activity of Wnt7a is related to the activation of a new non-canonical pathway implicating stimulatory G protein, Gαs.
3.2.4. Relation between Wnt4 and Myostatin
Myostatin acts through the receptor-associated proteins Smad2 and Smad3 [33,212,213]. Phosphorylated Smad2 and Smad3 form heterodimeric complex with the common mediator Smad4. These activated Smad proteins function as the key intracellular mediators of signaling for myostatin as they translocate into the nucleus, and activate the transcription of the target genes through interaction with DNA and other nuclear factors [214,215]. Takata et al. reported that Wnt4 had no effect on Smad2 phosphorylation, but it antagonized Smad2 phosphorylation induced by Mstn in differentiated C2C12 myoblasts [60]. They suggest that Wnt4 exert its myogenic effect by acting against Mstn. By using CAGA reporter assay, Bernardi et al. confirmed the inhibition of Mstn-activated Smad signaling pathway by Wnt4 [37]. Contrary to differentiated myoblasts, Wnt4 decreased the CAGA reporter activity in proliferating myoblasts below the basal level meaning that Wnt4 has a stronger anti-Mstn activity during proliferation than during differentiation. Furthermore, the fact that the addition of Mstn did not reverse the Wnt4-induced CAGA reporter inhibition in myoblasts and satellite cells suggests that Mstn acts upstream of Wnt4 or that Wnt4 regulates the Mstn/Smad pathway independently of Mstn. The inhibition of the Mstn pathway by Wnt4 can be associated with the inhibition of Mstn expression and/or inhibition of the Mstn/Smad transduction pathway. By using sqRT-PCR and promoter reporter experiments, authors showed that Wnt4 acted as an inhibitor of Mstn expression. Moreover, study with LiCl, strongly suggests that Wnt4 regulates negatively Mstn expression through activation of the canonical β-catenin pathway. However, while Wnt4 down-regulates Mstn expression in proliferative and differentiated cells, the activation of canonical signaling by LiCl inhibits Mstn expression only when cells are in proliferative or early differentiated states. Thus, in function of the differentiation state, various signaling pathways can be implicated in the inhibition of Mstn expression by Wnt4 in myogenic cells. A biphasic mode of action of Wnt4 can be proposed: in proliferative and early differentiated stages, Wnt4 acts by inducing canonical signaling, and later in the differentiation, canonical pathways is relaxed and another pathway maintains Mstn at low level. However, the fact that Wnt4 displayed the strongest CAGA reporter inhibiting activity in proliferative myoblasts, whereas Wnt4 had the strongest Mstn expression inhibiting activity in differentiated myoblasts, implies that Wnt4 regulates both Mstn expression and Mstn/Smad signaling pathway. In silico analysis in the Mstn promoter revealed the presence of three putative Tcf/LEF binding sites within a 2-kb sequence upstream of the
Mstn has been described as an inhibitor of myotube formation in C2C12 and satellite cells [32,33,34,35]. The reversion of Wnt4 activity by recombinant Mstn and the absence of hypertrophic activity of this factor in Mstn-/- mice demonstrated clearly that Wnt4 requires the presence of Mstn to elicit its differentiation promoting activity [37]. Thus the negative regulation of Mstn by Wnt4 is a crucial step for the myotube formation and hypertrophy. The fact that the addition of Mstn reverses the hypertrophic activity of Wnt4 but does not reverse the Wnt4-induced CAGA reporter inhibition implies that
4. Conclusion
Development, growth and maintenance of muscle mass are critical for long-term health and quality of life. In this regard, activation of satellite cells and regulation of anabolic/catabolic muscular pathways play key roles. Production of new myofibrils and degradation of existing proteins is a delicate equilibrium, which, depending on the condition, can promote muscle growth or loss. In this matter, skeletal muscle has the capacity to continuously regulate its size in response to a variety of external cues and serves as the most significant repository for protein in the body of healthy adult humans (~50% total protein content). To achieve a correct development and to maintain homeostasis, the biological response of the skeletal muscle implies a multitude of regulatory signaling pathways that orchestrates myogenesis in embryonic development and enables adult muscle repair. There is much interest in understanding the cellular and molecular mechanisms underlying skeletal muscle homeostasis and regeneration in different contexts because such knowledge might help in the development of cell therapies for diseases characterized by skeletal muscle degeneration. As described in this review, it is clear that Wnt play multiple and essential actions both in developmental and postnatal muscles. Depending not only of the Wnt signaling pathways implicated but also of the other interacting signaling pathways, Wnt proteins can act to promote or inhibit myogenesis. Further study will be necessary to elucidate the complex network that regulates embryonic and adult myogenesis.
References
- 1.
Kusserow A. Pang K. Sturm C. Hrouda M. Lentfer J. et al. 2005 Unexpected complexity of the Wnt gene family in a sea anemone. Nature433 156 160 - 2.
Borello U. Berarducci B. Murphy P. Bajard L. Buffa V. et al. 2006 The Wnt/beta-catenin pathway regulates Gli-mediated Myf5 expression during somitogenesis. Development133 3723 3732 - 3.
Moon R. T. Bowerman B. Boutros M. Perrimon N. 2002 The promise and perils of Wnt signaling through beta-catenin. Science296 1644 1646 - 4.
Cadigan K. M. Nusse R. 1997 Wnt signaling: a common theme in animal development. Genes Dev11 3286 3305 - 5.
Church V. L. Francis-West P. 2002 Wnt signalling during limb development. Int J Dev Biol46 927 936 - 6.
Veeman MT, Axelrod JD, Moon RT 2003 A second canon. Functions and mechanisms of beta-catenin-independent Wnt signaling. Dev Cell5 367 377 - 7.
Logan C. Y. Nusse R. 2004 The Wnt signaling pathway in development and disease. Annu Rev Cell Dev Biol20 781 810 - 8.
Abiola M. Favier M. Christodoulou-Vafeiadou E. Pichard A. L. Martelly I. et al. 2009 Activation of Wnt/beta-catenin signaling increases insulin sensitivity through a reciprocal regulation of Wnt10b and SREBP-1c in skeletal muscle cells. PLoS One 4: e8509. - 9.
Brisken C. Heineman A. Chavarria T. Elenbaas B. Tan J. et al. 2000 Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes Dev14 650 654 - 10.
Kim Y. Kobayashi A. Sekido R. Di Napoli L. Brennan J. et al. 2006 Fgf9 and Wnt4 act as antagonistic signals to regulate mammalian sex determination. PLoS Biol 4: e187. - 11.
Nishizuka M. Koyanagi A. Osada S. Imagawa M. 2008 Wnt4 and Wnt5a promote adipocyte differentiation. FEBS Lett582 3201 3205 - 12.
Park JS, Valerius MT, McMahon AP 2007 Wnt/beta-catenin signaling regulates nephron induction during mouse kidney development. Development134 2533 2539 - 13.
Bryja V. Schambony A. Cajanek L. Dominguez I. Arenas E. et al. 2008 Beta-arrestin and casein kinase 1/2 define distinct branches of non-canonical WNT signalling pathways. EMBO Rep9 1244 1250 - 14.
Kohn AD, Moon RT 2005 Wnt and calcium signaling: beta-catenin-independent pathways. Cell Calcium38 439 446 - 15.
Koyanagi M. Haendeler J. Badorff C. Brandes R. P. Hoffmann J. et al. 2005 Non-canonical Wnt signaling enhances differentiation of human circulating progenitor cells to cardiomyogenic cells. J Biol Chem280 16838 16842 - 16.
Minami Y. Oishi I. Endo M. Nishita M. 2010 Ror-family receptor tyrosine kinases in noncanonical Wnt signaling: their implications in developmental morphogenesis and human diseases. Dev Dyn239 1 15 - 17.
Tu X. Joeng K. S. Nakayama K. I. Nakayama K. Rajagopal J. et al. 2007 Noncanonical Wnt signaling through G protein-linked PKCdelta activation promotes bone formation. Dev Cell12 113 127 - 18.
Neumann CJ, Cohen SM 1997 Long-range action of Wingless organizes the dorsal-ventral axis of the Drosophila wing. Development124 871 880 - 19.
Strigini M. Cohen S. M. 2000 Wingless gradient formation in the Drosophila wing. Curr Biol10 293 300 - 20.
Zecca M. Basler K. Struhl G. 1996 Direct and long-range action of a wingless morphogen gradient. Cell87 833 844 - 21.
Bischoff R. 1975 Regeneration of single skeletal muscle fibers in vitro. Anat Rec182 215 235 - 22.
Konigsberg UR, Lipton BH, Konigsberg IR 1975 The regenerative response of single mature muscle fibers isolated in vitro. Dev Biol45 260 275 - 23.
Lipton B. H. Schultz E. 1979 Developmental fate of skeletal muscle satellite cells. Science205 1292 1294 - 24.
AS Brack Conboy. MJ Roy S. Lee M. Kuo C. J. et al. 2007 Increased Wnt signaling during aging alters muscle stem cell fate and increases fibrosis. Science317 807 810 - 25.
Munsterberg A. E. Kitajewski J. Bumcrot D. A. Mc Mahon A. P. Lassar A. B. 1995 Combinatorial signaling by Sonic hedgehog and Wnt family members induces myogenic bHLH gene expression in the somite. Genes Dev9 2911 2922 - 26.
Polesskaya A. Seale P. MA Rudnicki 2003 Wnt signaling induces the myogenic specification of resident CD45+ adult stem cells during muscle regeneration. Cell113 841 852 - 27.
von Maltzahn. J. Bentzinger C. F. MA Rudnicki 2012 Wnt7a-Fzd7 signalling directly activates the Akt/mTOR anabolic growth pathway in skeletal muscle. Nat Cell Biol14 186 191 - 28.
CA Steelman Recknor. J. C. Nettleton D. Reecy J. M. 2006 Transcriptional profiling of myostatin-knockout mice implicates Wnt signaling in postnatal skeletal muscle growth and hypertrophy. Faseb J20 580 582 - 29.
Kambadur R. Sharma M. Smith T. P. Bass J. J. 1997 Mutations in myostatin (GDF8) in double-muscled Belgian Blue and Piedmontese cattle. Genome Res7 910 916 - 30.
McPherron AC, Lawler AM, Lee SJ 1997 Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature387 83 90 - 31.
Williams MS 2004 Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med351 1030 1031 author reply 1030-1031. - 32.
Joulia D. Bernardi H. Garandel V. Rabenoelina F. Vernus B. et al. 2003 Mechanisms involved in the inhibition of myoblast proliferation and differentiation by myostatin. Exp Cell Res286 263 275 - 33.
Langley B. Thomas M. Bishop A. Sharma M. Gilmour S. et al. 2002 Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J Biol Chem277 49831 49840 - 34.
Rios R. Carneiro I. Arce V. M. Devesa J. 2002 Myostatin is an inhibitor of myogenic differentiation. Am J Physiol Cell Physiol 282: C993 999 - 35.
Trendelenburg A. U. Meyer A. Rohner D. Boyle J. Hatakeyama S. et al. 2009 Myostatin reduces Akt/TORC1/70S6K signaling, inhibiting myoblast differentiation and myotube size. Am J Physiol Cell Physiol 296: C1258-1270. - 36.
Guo W. Flanagan J. Jasuja R. Kirkland J. Jiang L. et al. 2008 The effects of myostatin on adipogenic differentiation of human bone marrow-derived mesenchymal stem cells are mediated through cross-communication between Smad3 and Wnt/beta-catenin signaling pathways. J Biol Chem283 9136 9145 - 37.
Bernardi H. Gay S. Fedon Y. Vernus B. Bonnieu A. et al. 2011 Wnt4 activates the canonical beta-catenin pathway and regulates negatively myostatin: functional implication in myogenesis. Am J Physiol Cell Physiol 300: C1122 1138 - 38.
Wodarz A. Nusse R. 1998 Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol14 59 88 - 39.
Fradkin L. G. Noordermeer J. N. Nusse R. 1995 The Drosophila Wnt protein DWnt-3 is a secreted glycoprotein localized on the axon tracts of the embryonic CNS. Dev Biol168 202 213 - 40.
Miller JR 2002 The Wnts. Genome Biol 3: REVIEWS3001. - 41.
Willert K. JD Brown Danenberg. E. Duncan A. W. Weissman I. L. et al. 2003 Wnt proteins are lipid-modified and can act as stem cell growth factors. Nature423 448 452 - 42.
Mason J. O. Kitajewski J. Varmus H. E. 1992 Mutational analysis of mouse Wnt-1 identifies two temperature-sensitive alleles and attributes of Wnt-1 protein essential for transformation of a mammary cell line. Mol Biol Cell3 521 533 - 43.
Zakin L. D. Mazan S. Maury M. Martin N. Guenet J. L. et al. 1998 Structure and expression of Wnt13, a novel mouse Wnt2 related gene. Mech Dev73 107 116 - 44.
Binari R. C. Staveley B. E. Johnson W. A. Godavarti R. Sasisekharan R. et al. 1997 Genetic evidence that heparin-like glycosaminoglycans are involved in wingless signaling. Development124 2623 2632 - 45.
Reichsman F. Smith L. Cumberledge S. 1996 Glycosaminoglycans can modulate extracellular localization of the wingless protein and promote signal transduction. J Cell Biol135 819 827 - 46.
Hausmann G. Banziger C. Basler K. 2007 Helping Wingless take flight: how WNT proteins are secreted. Nat Rev Mol Cell Biol8 331 336 - 47.
Neumann S. Coudreuse D. Y. van der Westhuyzen D. R. Eckhardt E. R. Korswagen H. C. et al. 2009 Mammalian Wnt3a is released on lipoprotein particles. Traffic10 334 343 - 48.
Panakova D. Sprong H. Marois E. Thiele C. Eaton S. 2005 Lipoprotein particles are required for Hedgehog and Wingless signalling. Nature435 58 65 - 49.
Schulte G. Bryja V. Rawal N. Castelo-Branco G. Sousa K. M. et al. 2005 Purified Wnt-5a increases differentiation of midbrain dopaminergic cells and dishevelled phosphorylation. J Neurochem92 1550 1553 - 50.
Yang-Snyder J. Miller J. R. JD Brown Lai. C. J. Moon R. T. 1996 A frizzled homolog functions in a vertebrate Wnt signaling pathway. Curr Biol6 1302 1306 - 51.
Huang HC, Klein PS 2004 The Frizzled family: receptors for multiple signal transduction pathways. Genome Biol 5: 234. - 52.
Mikels A. J. Nusse R. 2006 Wnts as ligands: processing, secretion and reception. Oncogene25 7461 7468 - 53.
Wong GT, Gavin BJ, McMahon AP 1994 Differential transformation of mammary epithelial cells by Wnt genes. Mol Cell Biol14 6278 6286 - 54.
Shimizu H. MA Julius Giarre. M. Zheng Z. Brown A. M. et al. 1997 Transformation by Wnt family proteins correlates with regulation of beta-catenin. Cell Growth Differ8 1349 1358 - 55.
Bernard P. Fleming A. Lacombe A. Harley V. R. Vilain E. 2008 Wnt4 inhibits beta-catenin/TCF signalling by redirecting beta-catenin to the cell membrane. Biol Cell100 167 177 - 56.
Jordan B. K. Shen J. H. Olaso R. Ingraham H. A. Vilain E. 2003 Wnt4 overexpression disrupts normal testicular vasculature and inhibits testosterone synthesis by repressing steroidogenic factor 1/beta-catenin synergy. Proc Natl Acad Sci U S A100 10866 10871 - 57.
Liu C. F. Parker K. Yao H. H. 2010 WNT4/beta-catenin pathway maintains female germ cell survival by inhibiting activin betaB in the mouse fetal ovary. PLoS One 5: e10382. - 58.
Lyons J. P. Mueller U. W. Ji H. Everett C. Fang X. et al. 2004 Wnt-4 activates the canonical beta-catenin-mediated Wnt pathway and binds Frizzled-6 CRD: functional implications of Wnt/beta-catenin activity in kidney epithelial cells. Exp Cell Res298 369 387 - 59.
Surendran K. Mc Caul S. P. Simon T. C. 2002 A role for Wnt-4 in renal fibrosis. Am J Physiol Renal Physiol 282: F431 441 - 60.
Takata H. Terada K. Oka H. Sunada Y. Moriguchi T. et al. 2007 Involvement of Wnt4 signaling during myogenic proliferation and differentiation of skeletal muscle. Dev Dyn236 2800 2807 - 61.
Terada Y. Tanaka H. Okado T. Shimamura H. Inoshita S. et al. 2003 Expression and function of the developmental gene Wnt-4 during experimental acute renal failure in rats. J Am Soc Nephrol14 1223 1233 - 62.
Le Grand F. Jones A. E. Seale V. Scime A. MA Rudnicki 2009 Wnt7a activates the planar cell polarity pathway to drive the symmetric expansion of satellite stem cells. Cell Stem Cell4 535 547 - 63.
Kengaku M. Capdevila J. Rodriguez-Esteban C. De La Pena J. Johnson R. L. et al. 1998 Distinct WNT pathways regulating AER formation and dorsoventral polarity in the chick limb bud. Science280 1274 1277 - 64.
Strutt D. I. Weber U. Mlodzik M. 1997 The role of RhoA in tissue polarity and Frizzled signalling. Nature387 292 295 - 65.
Boutros M. Mlodzik M. 1999 Dishevelled: at the crossroads of divergent intracellular signaling pathways. Mech Dev83 27 37 - 66.
Habas R. Kato Y. He X. 2001 Wnt/Frizzled activation of Rho regulates vertebrate gastrulation and requires a novel Formin homology protein Daam1. Cell107 843 854 - 67.
Winter C. G. Wang B. Ballew A. Royou A. Karess R. et al. 2001 Drosophila Rho-associated kinase (Drok) links Frizzled-mediated planar cell polarity signaling to the actin cytoskeleton. Cell105 81 91 - 68.
Fanto M. Mc Neill H. 2004 Planar polarity from flies to vertebrates. J Cell Sci117 527 533 - 69.
Bhanot P. Brink M. Samos C. H. Hsieh J. C. Wang Y. et al. 1996 A new member of the frizzled family from Drosophila functions as a Wingless receptor. Nature382 225 230 - 70.
Bhat KM 1998 frizzled and frizzled 2 play a partially redundant role in wingless signaling and have similar requirements to wingless in neurogenesis. Cell95 1027 1036 - 71.
Hsieh J. C. Rattner A. Smallwood P. M. Nathans J. 1999 Biochemical characterization of Wnt-frizzled interactions using a soluble, biologically active vertebrate Wnt protein. Proc Natl Acad Sci U S A96 3546 3551 - 72.
Chen C. M. Strapps W. Tomlinson A. Struhl G. 2004 Evidence that the cysteine-rich domain of Drosophila Frizzled family receptors is dispensable for transducing Wingless. Proc Natl Acad Sci U S A101 15961 15966 - 73.
Zhang J. Carthew R. W. 1998 Interactions between Wingless and DFz2 during Drosophila wing development. Development125 3075 3085 - 74.
CE Dann Hsieh. J. C. Rattner A. Sharma D. Nathans J. et al. 2001 Insights into Wnt binding and signalling from the structures of two Frizzled cysteine-rich domains. Nature412 86 90 - 75.
Hsieh JC 2004 Specificity of WNT-receptor interactions. Front Biosci9 1333 1338 - 76.
Rulifson E. J. Wu C. H. Nusse R. 2000 Pathway specificity by the bifunctional receptor frizzled is determined by affinity for wingless. Mol Cell6 117 126 - 77.
Nusse R. Rulifson E. Fish M. Harryman-Samos C. Brink M. et al. 2000 Interactions between wingless and frizzled molecules in Drosophila. Ernst Schering Res Found Workshop:1 11 - 78.
Cadigan KM, Liu YI 2006 Wnt signaling: complexity at the surface. J Cell Sci119 395 402 - 79.
He X. Semenov M. Tamai K. Zeng X. 2004 LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development131 1663 1677 - 80.
Tamai K. Semenov M. Kato Y. Spokony R. Liu C. et al. 2000 LDL-receptor-related proteins in Wnt signal transduction. Nature407 530 535 - 81.
Kato M. MS Patel Levasseur. R. Lobov I. Chang B. H. et al. 2002 Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor. J Cell Biol157 303 314 - 82.
Liu G. Bafico A. Harris V. K. Aaronson S. A. 2003 A novel mechanism for Wnt activation of canonical signaling through the LRP6 receptor. Mol Cell Biol23 5825 5835 - 83.
Cong F. Schweizer L. Varmus H. 2004 Wnt signals across the plasma membrane to activate the beta-catenin pathway by forming oligomers containing its receptors, Frizzled and LRP. Development131 5103 5115 - 84.
Pinson K. I. Brennan J. Monkley S. Avery B. J. Skarnes W. C. 2000 An LDL-receptor-related protein mediates Wnt signalling in mice. Nature407 535 538 - 85.
Wehrli M. Dougan S. T. Caldwell K. O’Keefe L. Schwartz S. et al. 2000 arrow encodes an LDL-receptor-related protein essential for Wingless signalling. Nature407 527 530 - 86.
Jones S. E. Jomary C. 2002 Secreted Frizzled-related proteins: searching for relationships and patterns. Bioessays24 811 820 - 87.
Glinka A. Wu W. Delius H. Monaghan A. P. Blumenstock C. et al. 1998 Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature391 357 362 - 88.
Krupnik V. E. JD Sharp Jiang. C. Robison K. Chickering T. W. et al. 1999 Functional and structural diversity of the human Dickkopf gene family. Gene238 301 313 - 89.
Kawano Y. Kypta R. 2003 Secreted antagonists of the Wnt signalling pathway. J Cell Sci116 2627 2634 - 90.
Rattner A. Hsieh J. C. Smallwood P. M. Gilbert D. J. Copeland N. G. et al. 1997 A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors. Proc Natl Acad Sci U S A94 2859 2863 - 91.
Melkonyan H. S. Chang W. C. Shapiro J. P. Mahadevappa M. Fitzpatrick P. A. et al. 1997 SARPs: a family of secreted apoptosis-related proteins. Proc Natl Acad Sci U S A94 13636 13641 - 92.
Uren A. Reichsman F. Anest V. Taylor W. G. Muraiso K. et al. 2000 Secreted frizzled-related protein-1 binds directly to Wingless and is a biphasic modulator of Wnt signaling. J Biol Chem275 4374 4382 - 93.
Lin K. Wang S. MA Julius Kitajewski. J. Moos M. Jr et al. 1997 The cysteine-rich frizzled domain of Frzb-1 is required and sufficient for modulation of Wnt signaling. Proc Natl Acad Sci U S A94 11196 11200 - 94.
Banyai L. Patthy L. 1999 The NTR module: domains of netrins, secreted frizzled related proteins, and type I procollagen C-proteinase enhancer protein are homologous with tissue inhibitors of metalloproteases. Protein Sci8 1636 1642 - 95.
Bafico A. Liu G. Yaniv A. Gazit A. Aaronson S. A. 2001 Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow. Nat Cell Biol3 683 686 - 96.
Wharton K. A. Jr 2003 Runnin’ with the Dvl: proteins that associate with Dsh/Dvl and their significance to Wnt signal transduction. Dev Biol253 1 17 - 97.
Miller JR, Hocking AM, Brown JD, Moon RT 1999 Mechanism and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca2+ pathways. Oncogene18 7860 7872 - 98.
Wallingford JB, Fraser SE, Harland RM 2002 Convergent extension: the molecular control of polarized cell movement during embryonic development. Dev Cell2 695 706 - 99.
Marlow F. Topczewski J. Sepich D. Solnica-Krezel L. 2002 Zebrafish Rho kinase 2 acts downstream of Wnt11 to mediate cell polarity and effective convergence and extension movements. Curr Biol12 876 884 - 100.
CA Franco Liebner. S. Gerhardt H. 2009 Vascular morphogenesis: a Wnt for every vessel? Curr Opin Genet Dev19 476 483 - 101.
Miller JR, Moon RT 1996 Signal transduction through beta-catenin and specification of cell fate during embryogenesis. Genes Dev10 2527 2539 - 102.
Willert K. Nusse R. 1998 Beta-catenin: a key mediator of Wnt signaling. Curr Opin Genet Dev8 95 102 - 103.
Rubinfeld B. Albert I. Porfiri E. Fiol C. Munemitsu S. et al. 1996 Binding of GSK3beta to the APC-beta-catenin complex and regulation of complex assembly. Science272 1023 1026 - 104.
Rubinfeld B. Souza B. Albert I. Muller O. Chamberlain S. H. et al. 1993 Association of the APC gene product with beta-catenin. Science262 1731 1734 - 105.
Su L. K. Vogelstein B. Kinzler K. W. 1993 Association of the APC tumor suppressor protein with catenins. Science262 1734 1737 - 106.
Yost C. Farr G. H. 3rd Pierce S. B. Ferkey D. M. MM Chen et. al 1998 GBP, an inhibitor of GSK-3, is implicated in Xenopus development and oncogenesis. Cell93 1031 1041 - 107.
Zeng L. Fagotto F. Zhang T. Hsu W. Vasicek T. J. et al. 1997 The mouse Fused locus encodes Axin, an inhibitor of the Wnt signaling pathway that regulates embryonic axis formation. Cell90 181 192 - 108.
Yost C. Torres M. Miller J. R. Huang E. Kimelman D. et al. 1996 The axis-inducing activity, stability, and subcellular distribution of beta-catenin is regulated in Xenopus embryos by glycogen synthase kinase 3. Genes Dev10 1443 1454 - 109.
Aberle H. Bauer A. Stappert J. Kispert A. Kemler R. 1997 beta-catenin is a target for the ubiquitin-proteasome pathway. EMBO J16 3797 3804 - 110.
Morin P. J. Sparks A. B. Korinek V. Barker N. Clevers H. et al. 1997 Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science275 1787 1790 - 111.
Rubinfeld B. Robbins P. El -Gamil M. Albert I. Porfiri E. et al. 1997 Stabilization of beta-catenin by genetic defects in melanoma cell lines. Science275 1790 1792 - 112.
Itoh K. Brott B. K. Bae G. U. MJ Ratcliffe Sokol. S. Y. 2005 Nuclear localization is required for Dishevelled function in Wnt/beta-catenin signaling. J Biol 4: 3. - 113.
Behrens J. von Kries. J. P. Kuhl M. Bruhn L. Wedlich D. et al. 1996 Functional interaction of beta-catenin with the transcription factor LEF-1. Nature382 638 642 - 114.
Molenaar M. van de Wetering M. Oosterwegel M. Peterson-Maduro J. Godsave S. et al. 1996 XTcf-3 transcription factor mediates beta-catenin-induced axis formation in Xenopus embryos. Cell86 391 399 - 115.
van de Wetering M. Cavallo R. Dooijes D. van Beest M. van Es J. et al. 1997 Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF. Cell88 789 799 - 116.
Brannon M. JD Brown Bates. R. Kimelman D. Moon R. T. 1999 XCtBP is a XTcf-3 co-repressor with roles throughout Xenopus development. Development126 3159 3170 - 117.
Nelson W. J. Nusse R. 2004 Convergence of Wnt, beta-catenin, and cadherin pathways. Science303 1483 1487 - 118.
Perez-Moreno M. Fuchs E. 2006 Catenins: keeping cells from getting their signals crossed. Dev Cell11 601 612 - 119.
Hecht A. Kemler R. 2000 Curbing the nuclear activities of beta-catenin. Control over Wnt target gene expression. EMBO Rep1 24 28 - 120.
Wang HY, Malbon CC 2003 Wnt signaling, Ca2+, and cyclic GMP: visualizing Frizzled functions. Science300 1529 1530 - 121.
Kuhl M. Sheldahl L. C. Park M. Miller J. R. Moon R. T. 2000 The Wnt/Ca2+ pathway: a new vertebrate Wnt signaling pathway takes shape. Trends Genet16 279 283 - 122.
Kuhl M. Sheldahl L. C. Malbon C. C. Moon R. T. 2000 Ca(2+)/calmodulin-dependent protein kinase II is stimulated by Wnt and Frizzled homologs and promotes ventral cell fates in Xenopus. J Biol Chem275 12701 12711 - 123.
Slusarski DC, Corces VG, Moon RT 1997 Interaction of Wnt and a Frizzled homologue triggers G-protein-linked phosphatidylinositol signalling. Nature390 410 413 - 124.
Nusse R. 1999 WNT targets. Repression and activation. Trends Genet15 1 3 - 125.
Vladar E. K. Antic D. JD Axelrod 2009 Planar cell polarity signaling: the developing cell’s compass. Cold Spring Harb Perspect Biol 1: a002964. - 126.
Strutt D. Warrington S. J. 2008 Planar polarity genes in the Drosophila wing regulate the localisation of the FH3-domain protein Multiple Wing Hairs to control the site of hair production. Development135 3103 3111 - 127.
Katoh M. 2005 WNT/PCP signaling pathway and human cancer (review). Oncol Rep14 1583 1588 - 128.
Buckingham M. Bajard L. Chang T. Daubas P. Hadchouel J. et al. 2003 The formation of skeletal muscle: from somite to limb. J Anat202 59 68 - 129.
Parker M. H. Seale P. MA Rudnicki 2003 Looking back to the embryo: defining transcriptional networks in adult myogenesis. Nat Rev Genet4 497 507 - 130.
Gridley T. 2006 The long and short of it: somite formation in mice. Dev Dyn235 2330 2336 - 131.
Gilbert SF 2003 The morphogenesis of evolutionary developmental biology. Int J Dev Biol47 467 477 - 132.
Tajbakhsh S. Borello U. Vivarelli E. Kelly R. Papkoff J. et al. 1998 Differential activation of Myf5 and MyoD by different Wnts in explants of mouse paraxial mesoderm and the later activation of myogenesis in the absence of Myf5. Development125 4155 4162 - 133.
Hollway G. Currie P. 2005 Vertebrate myotome development. Birth Defects Res C Embryo Today75 172 179 - 134.
Brent AE, Tabin CJ 2002 Developmental regulation of somite derivatives: muscle, cartilage and tendon. Curr Opin Genet Dev12 548 557 - 135.
Ordahl CP, Le Douarin NM 1992 Two myogenic lineages within the developing somite. Development114 339 353 - 136.
Kassar-Duchossoy L. Giacone E. Gayraud-Morel B. Jory A. Gomes D. et al. 2005 Pax3/Pax7 mark a novel population of primitive myogenic cells during development. Genes Dev19 1426 1431 - 137.
Braun T. MA Rudnicki Arnold. H. H. Jaenisch R. 1992 Targeted inactivation of the muscle regulatory gene Myf-5 results in abnormal rib development and perinatal death. Cell71 369 382 - 138.
Tajbakhsh S. Rocancourt D. Buckingham M. 1996 Muscle progenitor cells failing to respond to positional cues adopt non-myogenic fates in myf-5 null mice. Nature384 266 270 - 139.
Lagha M. Sato T. Bajard L. Daubas P. Esner M. et al. 2008 Regulation of skeletal muscle stem cell behavior by Pax3 and Pax7. Cold Spring Harb Symp Quant Biol73 307 315 - 140.
Francis-West P. H. Antoni L. Anakwe K. 2003 Regulation of myogenic differentiation in the developing limb bud. J Anat202 69 81 - 141.
Buckingham M. 2006 Myogenic progenitor cells and skeletal myogenesis in vertebrates. Curr Opin Genet Dev16 525 532 - 142.
Tajbakhsh S. Rocancourt D. Cossu G. Buckingham M. 1997 Redefining the genetic hierarchies controlling skeletal myogenesis: Pax-3 and Myf-5 act upstream of MyoD. Cell89 127 138 - 143.
Relaix F. Rocancourt D. Mansouri A. Buckingham M. 2005 A Pax3/Pax7-dependent population of skeletal muscle progenitor cells. Nature435 948 953 - 144.
Buckingham M. 2007 Skeletal muscle progenitor cells and the role of Pax genes. C R Biol330 530 533 - 145.
Gros J. Manceau M. Thome V. Marcelle C. 2005 A common somitic origin for embryonic muscle progenitors and satellite cells. Nature435 954 958 - 146.
Schultz E. 1996 Satellite cell proliferative compartments in growing skeletal muscles. Dev Biol175 84 94 - 147.
Ben-Yair R. Kalcheim C. 2008 Notch and bone morphogenetic protein differentially act on dermomyotome cells to generate endothelium, smooth, and striated muscle. J Cell Biol180 607 618 - 148.
Vasyutina E. Lenhard D. C. Birchmeier C. 2007 Notch function in myogenesis. Cell Cycle6 1451 1454 - 149.
Cossu G. Borello U. 1999 Wnt signaling and the activation of myogenesis in mammals. Embo J18 6867 6872 - 150.
Teillet M. Watanabe Y. Jeffs P. Duprez D. Lapointe F. et al. 1998 Sonic hedgehog is required for survival of both myogenic and chondrogenic somitic lineages. Development125 2019 2030 - 151.
Bentzinger CF, Wang YX, Rudnicki MA 2012 Building muscle: molecular regulation of myogenesis. Cold Spring Harb Perspect Biol 4. - 152.
Duprez D. Fournier-Thibault C. Le Douarin N. 1998 Sonic Hedgehog induces proliferation of committed skeletal muscle cells in the chick limb. Development125 495 505 - 153.
Christ B. Brand-Saberi B. 2002 Limb muscle development. Int J Dev Biol46 905 914 - 154.
Munsterberg AE, Lassar AB 1995 Combinatorial signals from the neural tube, floor plate and notochord induce myogenic bHLH gene expression in the somite. Development121 651 660 - 155.
Wagner J. Schmidt C. Nikowits W. Jr Christ B. 2000 Compartmentalization of the somite and myogenesis in chick embryos are influenced by wnt expression. Dev Biol228 86 94 - 156.
Cossu G. Kelly R. Tajbakhsh S. Di Donna S. Vivarelli E. et al. 1996 Activation of different myogenic pathways: myf-5 is induced by the neural tube and MyoD by the dorsal ectoderm in mouse paraxial mesoderm. Development122 429 437 - 157.
Borello U. Coletta M. Tajbakhsh S. Leyns L. De Robertis E. M. et al. 1999 Transplacental delivery of the Wnt antagonist Frzb1 inhibits development of caudal paraxial mesoderm and skeletal myogenesis in mouse embryos. Development126 4247 4255 - 158.
Gustafsson M. K. Pan H. Pinney D. F. Liu Y. Lewandowski A. et al. 2002 Myf5 is a direct target of long-range Shh signaling and Gli regulation for muscle specification. Genes Dev16 114 126 - 159.
Alvarez-Medina R. Cayuso J. Okubo T. Takada S. Marti E. 2008 Wnt canonical pathway restricts graded Shh/Gli patterning activity through the regulation of Gli3 expression. Development135 237 247 - 160.
Gros J. Serralbo O. Marcelle C. 2009 WNT11 acts as a directional cue to organize the elongation of early muscle fibres. Nature457 589 593 - 161.
Baksh D. Boland G. M. Tuan R. S. 2007 Cross-talk between Wnt signaling pathways in human mesenchymal stem cells leads to functional antagonism during osteogenic differentiation. J Cell Biochem101 1109 1124 - 162.
Baksh D. Tuan R. S. 2007 Canonical and non-canonical Wnts differentially affect the development potential of primary isolate of human bone marrow mesenchymal stem cells. J Cell Physiol212 817 826 - 163.
Thomas M. Langley B. Berry C. Sharma M. Kirk S. et al. 2000 Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J Biol Chem275 40235 40243 - 164.
Taylor W. E. Bhasin S. Artaza J. Byhower F. Azam M. et al. 2001 Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells. Am J Physiol Endocrinol Metab 280: E221 228 - 165.
Manceau M. Gros J. Savage K. Thome V. Mc Pherron A. et al. 2008 Myostatin promotes the terminal differentiation of embryonic muscle progenitors. Genes Dev22 668 681 - 166.
Kollias HD, McDermott JC 2008 Transforming growth factor-beta and myostatin signaling in skeletal muscle. J Appl Physiol104 579 587 - 167.
Grobet L. Martin L. J. Poncelet D. Pirottin D. Brouwers B. et al. 1997 A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nat Genet17 71 74 - 168.
McPherron AC, Lee SJ 1997 Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci U S A94 12457 12461 - 169.
Schuelke M. Wagner K. R. Stolz L. E. Hubner C. Riebel T. et al. 2004 Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med350 2682 2688 - 170.
Duprez D. Bell E. J. Richardson M. K. Archer C. W. Wolpert L. et al. 1996 Overexpression of BMP-2 and BMP-4 alters the size and shape of developing skeletal elements in the chick limb. Mech Dev57 145 157 - 171.
Sela-Donenfeld D. Kalcheim C. 2002 Localized BMP4-noggin interactions generate the dynamic patterning of noggin expression in somites. Dev Biol246 311 328 - 172.
Amthor H. Christ B. Rashid-Doubell F. Kemp C. F. Lang E. et al. 2002 Follistatin regulates bone morphogenetic protein-7 (BMP-7) activity to stimulate embryonic muscle growth. Dev Biol243 115 127 - 173.
Souza T. A. Chen X. Guo Y. Sava P. Zhang J. et al. 2008 Proteomic identification and functional validation of activins and bone morphogenetic protein 11 as candidate novel muscle mass regulators. Mol Endocrinol22 2689 2702 - 174.
McCarthy JJ 2008 MicroRNA-206: the skeletal muscle-specific myomiR. Biochim Biophys Acta1779 682 691 - 175.
Chen J. F. Mandel E. M. Thomson J. M. Wu Q. Callis T. E. et al. 2006 The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet38 228 233 - 176.
Sweetman D. Goljanek K. Rathjen T. Oustanina S. Braun T. et al. 2008 Specific requirements of MRFs for the expression of muscle specific microRNAs, miR-1, miR-206 and miR-133. Dev Biol321 491 499 - 177.
Tedesco F. S. Dellavalle A. Diaz-Manera J. Messina G. Cossu G. 2010 Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells. J Clin Invest120 11 19 - 178.
Cornelison DD, Wold BJ 1997 Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells. Dev Biol191 270 283 - 179.
Grounds MD, Garrett KL, Lai MC, Wright WE, Beilharz MW 1992 Identification of skeletal muscle precursor cells in vivo by use of MyoD1 and myogenin probes. Cell Tissue Res267 99 104 - 180.
Zammit PS 2008 All muscle satellite cells are equal, but are some more equal than others? J Cell Sci121 2975 2982 - 181.
Charge SB, Rudnicki MA 2004 Cellular and molecular regulation of muscle regeneration. Physiol Rev84 209 238 - 182.
Dhawan J. Rando T. A. 2005 Stem cells in postnatal myogenesis: molecular mechanisms of satellite cell quiescence, activation and replenishment. Trends Cell Biol15 666 673 - 183.
Price F. D. Kuroda K. MA Rudnicki 2007 Stem cell based therapies to treat muscular dystrophy. Biochim Biophys Acta1772 272 283 - 184.
Fukada S. Uezumi A. Ikemoto M. Masuda S. Segawa M. et al. 2007 Molecular signature of quiescent satellite cells in adult skeletal muscle. Stem Cells25 2448 2459 - 185.
Kuang S. MA Rudnicki 2008 The emerging biology of satellite cells and their therapeutic potential. Trends Mol Med14 82 91 - 186.
Sambasivan R. Tajbakhsh S. 2007 Skeletal muscle stem cell birth and properties. Semin Cell Dev Biol18 870 882 - 187.
Brack A. 2009 Adult muscle stem cells avoid death and Paxes. Cell Stem Cell5 132 134 - 188.
Tajbakhsh S. Bober E. Babinet C. Pournin S. Arnold H. et al. 1996 Gene targeting the myf-5 locus with nlacZ reveals expression of this myogenic factor in mature skeletal muscle fibres as well as early embryonic muscle. Dev Dyn206 291 300 - 189.
Zammit P. S. Golding J. P. Nagata Y. Hudon V. Partridge T. A. et al. 2004 Muscle satellite cells adopt divergent fates: a mechanism for self-renewal? J Cell Biol166 347 357 - 190.
Kuang S. Kuroda K. Le Grand F. MA Rudnicki 2007 Asymmetric self-renewal and commitment of satellite stem cells in muscle. Cell129 999 1010 - 191.
Kassar-Duchossoy L. Gayraud-Morel B. Gomes D. Rocancourt D. Buckingham M. et al. 2004 Mrf4 determines skeletal muscle identity in Myf5:Myod double-mutant mice. Nature431 466 471 - 192.
Shinin V. Gayraud-Morel B. Gomes D. Tajbakhsh S. 2006 Asymmetric division and cosegregation of template DNA strands in adult muscle satellite cells. Nat Cell Biol8 677 687 - 193.
Marcell TJ 2003 Sarcopenia: causes, consequences, and preventions. J Gerontol A Biol Sci Med Sci 58: M911 916 - 194.
Conboy IM, Conboy MJ, Smythe GM, Rando TA 2003 Notch-mediated restoration of regenerative potential to aged muscle. Science302 1575 1577 - 195.
Goldspink G. Fernandes K. Williams P. E. Wells D. J. 1994 Age-related changes in collagen gene expression in the muscles of mdx dystrophic and normal mice. Neuromuscul Disord4 183 191 - 196.
Conboy IM, Rando TA 2005 Aging, stem cells and tissue regeneration: lessons from muscle. Cell Cycle4 407 410 - 197.
Conboy IM, Conboy MJ, Wagers AJ, Girma ER, Weissman IL, et al. 2005 Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature433 760 764 - 198.
Liu H. MM Fergusson Castilho. R. M. Liu J. Cao L. et al. 2007 Augmented Wnt signaling in a mammalian model of accelerated aging. Science317 803 806 - 199.
Dellavalle A. Sampaolesi M. Tonlorenzi R. Tagliafico E. Sacchetti B. et al. 2007 Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells. Nat Cell Biol9 255 267 - 200.
Sampaolesi M. Blot S. D’Antona G. Granger N. Tonlorenzi R. et al. 2006 Mesoangioblast stem cells ameliorate muscle function in dystrophic dogs. Nature444 574 579 - 201.
Galvez B. G. Sampaolesi M. Brunelli S. Covarello D. Gavina M. et al. 2006 Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration ability. J Cell Biol174 231 243 - 202.
Sampaolesi M. Torrente Y. Innocenzi A. Tonlorenzi R. D’Antona G. et al. 2003 Cell therapy of alpha-sarcoglycan null dystrophic mice through intra-arterial delivery of mesoangioblasts. Science301 487 492 - 203.
Mitchell K. J. Pannerec A. Cadot B. Parlakian A. Besson V. et al. 2010 Identification and characterization of a non-satellite cell muscle resident progenitor during postnatal development. Nat Cell Biol12 257 266 - 204.
Gussoni E. Soneoka Y. Strickland C. D. Buzney E. A. Khan M. K. et al. 1999 Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature401 390 394 - 205.
LaBarge MA, Blau HM 2002 Biological progression from adult bone marrow to mononucleate muscle stem cell to multinucleate muscle fiber in response to injury. Cell111 589 601 - 206.
Tanaka S. Terada K. Nohno T. 2011 Canonical Wnt signaling is involved in switching from cell proliferation to myogenic differentiation of mouse myoblast cells. J Mol Signal 6: 12. - 207.
Otto A. Schmidt C. Luke G. Allen S. Valasek P. et al. 2008 Canonical Wnt signalling induces satellite-cell proliferation during adult skeletal muscle regeneration. J Cell Sci121 2939 2950 - 208.
Lathrop B. Olson E. Glaser L. 1985 Control by fibroblast growth factor of differentiation in the BC3H1 muscle cell line. J Cell Biol100 1540 1547 - 209.
Anakwe K. Robson L. Hadley J. Buxton P. Church V. et al. 2003 Wnt signalling regulates myogenic differentiation in the developing avian wing. Development130 3503 3514 - 210.
Armstrong DD, Wong VL, Esser KA 2006 Expression of beta-catenin is necessary for physiological growth of adult skeletal muscle. Am J Physiol Cell Physiol 291: C185 188 - 211.
Han X. H. Jin Y. R. Seto M. Yoon J. K. 2011 A WNT/beta-catenin signaling activator, R-spondin, plays positive regulatory roles during skeletal myogenesis. J Biol Chem286 10649 10659 - 212.
Bogdanovich S. Krag T. O. Barton E. R. Morris L. D. Whittemore L. A. et al. 2002 Functional improvement of dystrophic muscle by myostatin blockade. Nature420 418 421 - 213.
Rebbapragada A. Benchabane H. Wrana J. L. Celeste A. J. Attisano L. 2003 Myostatin signals through a transforming growth factor beta-like signaling pathway to block adipogenesis. Mol Cell Biol23 7230 7242 - 214.
Derynck R. Zhang Y. Feng X. H. 1998 Smads: transcriptional activators of TGF-beta responses. Cell95 737 740 - 215.
Massague J. Wotton D. 2000 Transcriptional control by the TGF-beta/Smad signaling system. Embo J19 1745 1754